Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Gotham Therapeutics

Request full access

Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery

New York City, United StatesFounded 2017Biotech & Life Sciences

About Gotham Therapeutics

Gotham Therapeutics is pioneering a novel drug class that targets the epitranscriptomics machinery, a critical component in mRNA biology. The company operates within the biopharma sector and serves clients in the medical and pharmaceutical industries. Gotham Therapeutics leverages its transatlantic presence, with operations in New York and a subsidiary near Munich, Germany, to attract top-tier talent and academic expertise. The business model focuses on target validation, drug discovery, and development, aiming to bring groundbreaking treatments to market. Revenue is generated through partnerships, licensing agreements, and potentially direct sales of developed drugs.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
New York City, United States
Employees
1
Open positions
None listed
Dealroom signal
27.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Oct 2018 $54M $216M Versant Ventures · Forbion Capital Partners · SR One —
SPINOUTOther financing Jan 2017 $0 — Weill Cornell —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Gotham Therapeutics website traffic

Latest recorded traffic for Gotham Therapeutics is 260 monthly website visits, down 72.6% over the last three months. Gotham Therapeutics's team grew 0% over the past year.

Latest monthly visits260 3-month web change-72.6% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Gotham Therapeutics in the New York City ecosystem

Live from Dealroom

The Gotham Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Other known investors1 additional known investor

  • Weill Cornell
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Gotham Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gotham Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.